Taxonomic review of Athliini (Coleoptera: Scarabaeidae: Melolonthinae), a new tribe of scarab beetles endemic to South America.

Zootaxa

Canadian Museum of Nature, P.O. Box 3443, Station D, Ottawa, Ontario, K1P 6P4, Canada..

Published: September 2018

Athliini Smith Evans, new tribe (Coleoptera: Scarabaeidae: Melolonthinae) includes four genera that occur from southern South America through to the southeastern regions of Brazil: Apteroathlia Smith Evans, new genus, Athlia Erichson, 1835, Dihymenonyx Gutiérrez, 1949, and Ulata Saylor, 1945. Justifications are provided for the new tribe and for the placement each genus in the new tribe. Keys to genera and species are presented along with distributional data and maps for all species. Apteroathlia translucida Smith Evans, new species and Apteroathlia nox Smith Evans, new species are described. Lectotypes are designated for Athlia bruchi Moser, 1924 and Athlia rustica Erichson, 1835. A neotype is designated for Ulata argentina Saylor, 1945.

Download full-text PDF

Source
http://dx.doi.org/10.11646/zootaxa.4471.2.3DOI Listing

Publication Analysis

Top Keywords

smith evans
16
coleoptera scarabaeidae
8
scarabaeidae melolonthinae
8
south america
8
erichson 1835
8
saylor 1945
8
species apteroathlia
8
evans species
8
taxonomic review
4
review athliini
4

Similar Publications

Background: People with diabetes are at increased risk of hospitalisation, morbidity, and mortality following SARS-CoV-2 infection. Long-term outcomes for people with diabetes previously hospitalised with COVID-19 are, however, unknown. This study aimed to determine the longer-term physical and mental health effects of COVID-19 in people with and without diabetes.

View Article and Find Full Text PDF

Antibody-drug conjugates (ADCs) combining monoclonal antibodies with cytotoxic payloads are a rapidly emerging class of immune-based therapeutics with the potential to improve the treatment of cancer, including children with relapse/refractory acute lymphoblastic leukemia (ALL). CD123, the α subunit of the interleukin-3 receptor, is overexpressed in ALL and is a potential therapeutic target. Here, we show that pivekimab sunirine (PVEK), a recently developed ADC comprising the CD123-targeting antibody, G4723A, and the cytotoxic payload, DGN549, was highly effective in vivo against a large panel of pediatric ALL patient-derived xenograft (PDX) models ( = 39).

View Article and Find Full Text PDF

Background: Significant differences in outcomes for mothers and babies following obstetric surgical interventions between low- and middle-income countries and high-income settings have demonstrated a need for improvements in quality of care and training of obstetric surgical and anaesthetic providers. To address this, a five-day face-to-face training intervention was developed. When roll-out was disrupted by the COVID-19 pandemic, the course was redesigned for delivery by blended learning.

View Article and Find Full Text PDF

Physiology education is at the core of biomedical science and medicine. Physiology unites multiple disciplines to explain the mechanisms whereby a risk factor is associated with disease. Race, ethnicity, sexual orientation, and gender identity are associated with risk of cardiovascular disease (CVD).

View Article and Find Full Text PDF

Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare type of non-Hodgkin lymphoma characterized by subcutaneous nodules, indurated plaques, erythema, and cellular infiltrates in the subcutaneous fat. Biopsies show neoplastic cells expressing cytotoxic T-cell markers and displaying moderate cytologic atypia while sparing the dermis and epidermis and showing variable degrees of necrosis, hemorrhage, and inflammatory changes. We describe a pediatric case of SPTCL in a 6-year-old boy, presenting with an unusual targetoid plaque and systemic symptoms, who showed significant improvement on systemic immunosuppressants without chemotherapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!